Vistagen Therapeutics notifies Nasdaq of audit committee non-compliance
#Vistagen Therapeutics #Nasdaq #audit committee #non-compliance #regulatory #stock exchange #listing
📌 Key Takeaways
- Vistagen Therapeutics reported non-compliance with Nasdaq audit committee requirements.
- The notification was made to Nasdaq, indicating a regulatory issue.
- The specific nature of the non-compliance was not detailed in the article.
- This could impact the company's listing status on the Nasdaq stock exchange.
🏷️ Themes
Regulatory Compliance, Corporate Governance
Entity Intersection Graph
No entity connections available yet for this article.